I get the call out on aggressive valuations for the labs (which should be litigated in public and…

I get the call out on aggressive valuations for the labs (which should be litigated in public and we’ll see how the IPOs do) but comparing multiples or against historical revenue without accounting for growth (amongst the fastest we’ve ever seen in capitalism) and the rapid 引用 @craigweiss：if meta w